Currently, there are 24.48B common shares owned by the public and among those 23.42B shares have been available to trade.
The company’s stock has a 5-day price change of 7.97% and -9.92% over the past three months. NVDA shares are trading -9.40% year to date (YTD), with the 12-month market performance up to 32.38% higher. It has a 12-month low price of $75.61 and touched a high of $153.13 over the same period. NVDA has an average intraday trading volume of 271.03 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -1.27%, -5.90%, and -4.68% respectively.
Institutional ownership of NVIDIA Corp (NASDAQ: NVDA) shares accounts for 66.32% of the company’s 24.48B shares outstanding.
It has a market capitalization of $2968.75B and a beta (3y monthly) value of 1.91. The stock’s trailing 12-month PE ratio is 41.39, while the earnings-per-share (ttm) stands at $2.94. The company has a PEG of 1.42 and a Quick Ratio of 3.88 with the debt-to-equity ratio at 0.13. Price movements for the stock have been influenced by the stock’s volatility, which stands at 4.65% over the week and 5.37% over the month.
Analysts forecast that NVIDIA Corp (NVDA) will achieve an EPS of 0.93 for the current quarter, 1.05 for the next quarter and 5.77 for current fiscal year. The lowest estimate earnings-per-share for the quarter is 0.91 while analysts give the company a high EPS estimate of 0.91. Comparatively, EPS for the current quarter was 0.61 a year ago. Earnings per share for the fiscal year are expected to increase by 51.96%, and 26.76% over the next financial year. EPS should shrink at an annualized rate of 29.16% over the next five years, compared to 91.83% over the past 5-year period.
Wells Fargo coverage for the NVIDIA Corp (NVDA) stock in a research note released on November 21, 2024 offered a Overweight rating with a price target of $185. Truist was of a view on November 21, 2024 that the stock is Buy, while The Benchmark Company gave the stock Buy rating on November 21, 2024, issuing a price target of $170- $190. TD Cowen on their part issued Buy rating on November 21, 2024.
